To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore

Clinical trial NCT01570439 · UNKNOWN

Trial details

NCT number: NCT01570439
Sponsor: National University Hospital, Singapore
Status: UNKNOWN
Study type: OBSERVATIONAL

Anonymous Donors at Blood Donation Center (NUH)

Start date: 2012-01-01
Primary completion: 2014-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.